Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01489306
What this trial is testing

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers

Who this might be right for
Drug Safety
MicroDose Therapeutx, Inc 36
Large-scale testing (Phase 3)Study completedNCT05568797
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,045
Testing effectiveness (Phase 2)Looking for participantsNCT06817889
What this trial is testing

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT06585150
What this trial is testing

Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
RSV Infection
Gilead Sciences 150
Not applicableStudy completedNCT05818215
What this trial is testing

Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns

Who this might be right for
EmergenciesEpidemic DiseasePediatric ALL+1 more
Pediatric Clinical Research Platform 18,000
Not applicableActive Not RecruitingNCT06640387
What this trial is testing

CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools

Who this might be right for
SARS CoV 2 InfectionRSV InfectionInfluenza+2 more
The Hospital for Sick Children 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Not applicableUnknownNCT04925310
What this trial is testing

Infection With Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)Respiratory Syncytial Virus-bronchiolitis
Hannover Medical School 350
Testing effectiveness (Phase 2)Study completedNCT06206720
What this trial is testing

Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infection
Vigonvita Life Sciences 60
Early research (Phase 1)Study completedNCT04295070
What this trial is testing

Safety and Immunogenicity of a Live-attenuated Vaccine Against Respiratory Syncytial Virus in Elderly Volunteers

Who this might be right for
Respiratory Syncytial Virus Infections
Codagenix, Inc 36
Post-approval studies (Phase 4)Study completedNCT00500578
What this trial is testing

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT04484935
What this trial is testing

Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children

Who this might be right for
RSV Infection
AstraZeneca 100
Early research (Phase 1)Study completedNCT05587478
What this trial is testing

EDP-323 in Healthy Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 82
Early research (Phase 1)Ended earlyNCT06102174
What this trial is testing

Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT04231968
What this trial is testing

AK0529 in Chinese Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 311
Not applicableStudy completedNCT00435994
What this trial is testing

Assessment of Airway Obstruction in Infants With Lower Respiratory Infections

Who this might be right for
BronchiolitisRespiratory Syncytial Virus Infections
Indiana University 59
Not applicableStudy completedNCT02984280
What this trial is testing

Specific Respiratory Infections as Triggers of Acute Medical Events

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus InfectionsParainfluenza+4 more
University College, London 787,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07578298
What this trial is testing

THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Infection Virus
Menzies School of Health Research 1,000
Large-scale testing (Phase 3)Study completedNCT00016081
What this trial is testing

Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation

Who this might be right for
Infection
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02654171
What this trial is testing

Viral Inhibition in Children for Treatment of RSV

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Shanghai Ark Biopharmaceutical Co., Ltd. 72
Next Page